Every day someone gets sick is one too many. Based on this motto, biopharmaceutical company Bristol Myers Squibb (BMS) has made it its mission to improve the lives of people with diseases through research and science.
With its focus on clinical research, the company plays a pioneering role in the treatment of cancer. “We rely heavily on immuno-oncology, which has the potential to significantly improve the lives of patients – especially in cases where treatment options were previously scarce,” explains Jens Weidner, Managing Director of BMS Austria.
Unlike previous therapies that directly attack the tumor or cancer cells, immuno-oncology agents activate the body’s natural ability to fight cancer. But Bristol Myers Squibb employees believe the pharmaceutical industry must do more than just deliver medicines to support patients and families.
Collaborations with hospitals
Through collaborations with university clinics and hospitals, the company promotes international exchange and the development of new therapies. Despite progress, the fight against cancer and other serious diseases remains a major challenge given demographic changes.
Source: Krone
I am an experienced and passionate journalist with a strong track record in news website reporting. I specialize in technology coverage, breaking stories on the latest developments and trends from around the world. Working for Today Times Live has given me the opportunity to write thought-provoking pieces that have caught the attention of many readers.
